Begin main content

Reports

We found 6501 result(s)

Why Organizations, Researchers, and Patients Are Falling Prey to Predatory Journals

Event Date: October 10, 2019
Result type: Events

Lecture Description This interactive talk will provide an overview of what predatory journals are and describe how they are having an impact on organizations, researchers, and patients. In doing so, the talk will touch on related topics including academic incentives, research funding, and science policy. It will discuss the impact of predatory ...

Why Oncology Needs More Common Sense and Less Cheerleading — A Case for a Centre for Sense in Oncology

Event Date: September 5, 2019
Result type: Events

Lecture Description This talk will walk the audience through various hypes, spins, conflicts, and biases distorting the practice of oncology, and provide recommendations on how to control or correct these issues. The aim is to educate the audience on how to detect such issues in oncology, develop a sense of cautious optimism (not all is bad, bu...

pCODR Provincial Advisory Group

Published on: August 21, 2019
Result type: General Content

A Provincial Advisory Group (PAG) is in place to provide advice to the CADTH pCODR Advisory Committee (PAC) about operational issues, as well as to inform strategic and policy direction. PAG reports to the PAC through its Chair. Input from PAG ensures that the pCODR drug review process, and the resulting recommendations, meet the needs of parti...

CADTH pan-Canadian Oncology Drug Review

Published on: August 21, 2019
Result type: General Content

The pan-Canadian Oncology Drug Review (pCODR) is an evidence-based, cancer drug review process. The pCODR process is designed to bring consistency and clarity to the assessment of cancer drugs by reviewing clinical evidence, cost-effectiveness, and patient perspectives, and using this information to make recommendations to Canada's provinces ...

cabotegravir sodium (TBC)

Last Updated: August 19, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: cabotegravir sodium
Indications: HIV-1 infection

  • Brand Name: TBC
  • Manufacturer: ViiV Healthcare ULC
  • Project Number: SR0628-001
  • Project Status: Received
  • Submission Type: NewCombination

cabotegravir/rilpivirine (TBC)

Last Updated: August 19, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: cabotegravir-rilpivirine
Indications: HIV-1 infection

  • Brand Name: TBC
  • Manufacturer: ViiV Healthcare ULC
  • Project Number: SR0628-000
  • Project Status: Received
  • Submission Type: NewCombination

lanadelumab (Takhzyro)

Last Updated: August 19, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: lanadelumab
Indications: Hereditary angioedema, prevention

  • Brand Name: Takhzyro
  • Manufacturer: Shire Pharma Canada ULC
  • Project Number: SR0618-000
  • Project Status: Active
  • Submission Type: New